Cargando…
Immunoregulatory Cells in Myasthenia Gravis
Myasthenia gravis (MG) is a T cell-dependent, B-cell mediated autoimmune disease caused by antibodies against the nicotinic acetylcholine receptor or other components of the post-synaptic muscle endplate at the neuromuscular junction. These specific antibodies serve as excellent biomarkers for diagn...
Autores principales: | Wu, Ying, Luo, Jie, Garden, Oliver A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769807/ https://www.ncbi.nlm.nih.gov/pubmed/33384654 http://dx.doi.org/10.3389/fneur.2020.593431 |
Ejemplares similares
-
A Systematic Review of the Potential Implication of Infectious Agents in Myasthenia Gravis
por: Leopardi, Victoria, et al.
Publicado: (2021) -
Exploring the role of immune checkpoint inhibitors in the etiology of myasthenia gravis and Lambert-Eaton myasthenic syndrome: A systematic review
por: Seligman, Carly, et al.
Publicado: (2023) -
Afterdischarges in Myasthenia Gravis
por: Yang, Li, et al.
Publicado: (2021) -
Novel Treatments in Myasthenia Gravis
por: Menon, Deepak, et al.
Publicado: (2020) -
Management of Juvenile Myasthenia Gravis
por: O'Connell, Karen, et al.
Publicado: (2020)